Table 3. Results of joinpoint regression analysis on the trends in all-cancer mortality: national data (1958–2018).
Age | Sex | Cancer site | ICD-10 | Number of joinpoints |
Line segment | Annual % change |
95% confidence interval |
|||
Start | End | Lower | Upper | |||||||
All ages | Male and female | All cancers | C00–C97 | 4 | 1958 | 1966 | 0.4 | 0.1 | 0.8 | * |
1966 | 1993 | −0.2 | −0.2 | −0.1 | * | |||||
1993 | 1997 | 0.6 | −0.3 | 1.5 | ||||||
1997 | 2015 | −1.4 | −1.4 | −1.3 | * | |||||
2015 | 2018 | −2.2 | −3.0 | −1.4 | * | |||||
All cancers excluding stomach | C00–C97 (excluding C16) | 5 | 1958 | 1975 | 1.1 | 1.0 | 1.2 | * | ||
1975 | 1984 | 1.7 | 1.5 | 1.9 | * | |||||
1984 | 1993 | 0.7 | 0.5 | 0.9 | * | |||||
1993 | 1997 | 1.4 | 0.6 | 2.2 | * | |||||
1997 | 2016 | −1.0 | −1.1 | −1.0 | * | |||||
2016 | 2018 | −2.3 | −3.8 | −0.9 | * | |||||
All cancers excluding stomach and liver | C00–C97 (excluding C16 and C22) | 4 | 1958 | 1984 | 1.5 | 1.4 | 1.5 | * | ||
1984 | 1992 | 0.5 | 0.2 | 0.7 | * | |||||
1992 | 1996 | 1.6 | 0.7 | 2.5 | * | |||||
1996 | 2015 | −0.6 | −0.6 | −0.5 | * | |||||
2015 | 2018 | −1.4 | −2.2 | −0.6 | * | |||||
Male | All cancers | C00–C97 | 4 | 1958 | 1988 | 0.5 | 0.5 | 0.6 | * | |
1988 | 1992 | −0.5 | −1.7 | 0.7 | ||||||
1992 | 1996 | 1.5 | 0.4 | 2.7 | * | |||||
1996 | 2013 | −1.6 | −1.6 | −1.5 | * | |||||
2013 | 2018 | −2.5 | −2.9 | −2.0 | * | |||||
All cancers excluding stomach | C00–C97 (excluding C16) | 4 | 1958 | 1975 | 2.0 | 1.8 | 2.2 | * | ||
1975 | 1983 | 2.8 | 2.3 | 3.3 | * | |||||
1983 | 1997 | 1.3 | 1.2 | 1.4 | * | |||||
1997 | 2013 | −1.3 | −1.3 | −1.2 | * | |||||
2013 | 2018 | −2.1 | −2.5 | −1.6 | * | |||||
All cancers excluding stomach and liver | C00–C97 (excluding C16 and C22) | 4 | 1958 | 1963 | 3.6 | 2.2 | 5.0 | * | ||
1963 | 1982 | 2.4 | 2.3 | 2.5 | * | |||||
1982 | 1997 | 1.3 | 1.2 | 1.5 | * | |||||
1997 | 2014 | −0.8 | −0.9 | −0.7 | * | |||||
2014 | 2018 | −1.9 | −2.5 | −1.2 | * | |||||
All cancers excluding prostate | C00–C97 (excluding C61) | 4 | 1958 | 1987 | 0.5 | 0.4 | 0.5 | * | ||
1987 | 1992 | −0.4 | −1.1 | 0.4 | ||||||
1992 | 1996 | 1.2 | 0.1 | 2.4 | * | |||||
1996 | 2013 | −1.6 | −1.7 | −1.5 | * | |||||
2013 | 2018 | −2.5 | −2.9 | −2.0 | * | |||||
Female | All cancers | C00–C97 | 4 | 1958 | 1968 | −0.1 | −0.3 | 0.1 | ||
1968 | 1993 | −0.8 | −0.9 | −0.8 | * | |||||
1993 | 1997 | 0.5 | −0.4 | 1.4 | ||||||
1997 | 2003 | −1.4 | −1.8 | −1.0 | * | |||||
2003 | 2018 | −1.0 | −1.1 | −0.9 | * | |||||
All cancers excluding stomach | C00–C97 (excluding C16) | 4 | 1958 | 1976 | 0.1 | 0.0 | 0.2 | |||
1976 | 1980 | 1.0 | −0.2 | 2.2 | ||||||
1980 | 1993 | 0.2 | 0.0 | 0.3 | * | |||||
1993 | 1997 | 0.9 | 0.0 | 1.9 | * | |||||
1997 | 2018 | −0.7 | −0.8 | −0.7 | * | |||||
All cancers excluding stomach and liver | C00–C97 (excluding C16 and C22) | 5 | 1958 | 1976 | 0.4 | 0.3 | 0.5 | * | ||
1976 | 1981 | 0.9 | 0.2 | 1.7 | * | |||||
1981 | 1993 | 0.1 | −0.1 | 0.2 | ||||||
1993 | 1997 | 1.0 | 0.1 | 1.9 | * | |||||
1997 | 2003 | −0.8 | −1.2 | −0.4 | * | |||||
2003 | 2018 | −0.3 | −0.4 | −0.2 | * | |||||
All cancers excluding breast | C00–C97 (excluding C50) | 5 | 1958 | 1968 | −0.2 | −0.4 | 0.0 | |||
1968 | 1993 | −1.0 | −1.0 | −1.0 | * | |||||
1993 | 1997 | 0.1 | −0.8 | 0.9 | ||||||
1997 | 2007 | −1.6 | −1.7 | −1.4 | * | |||||
2007 | 2014 | −1.0 | −1.3 | −0.7 | * | |||||
2014 | 2018 | −1.7 | −2.3 | −1.1 | * |
ICD-10, International Classification of Diseases, 10th revision.
*Annual % change was statistically significantly different from zero (P < 0.05).